ICMR to hold workshop on clinical trials from Sept 15- 19 in Pune to empower ethical excellence in clinical research: Shardul Nautiyal, Mumbai Monday, July 21, 2025, 08:00 Hrs [IS ...

ICMR-developed vaccine targets two parasite stages, offers potential for long-term immunity and lower transmission ...

ICMR and Panacea Biotec conduct third phase trials for indigenous dengue vaccine in India with promising results.

India has taken a major step forward in the fight against malaria with the development of a new indigenous vaccine candidate ...

Enrolment of about 10,500 participants in the phase III clinical trial of the indigenous one-shot Panacea Biotec developed ...

In a significant breakthrough towards eliminating malaria, India has announced the development of AdFalciVax, a next-generation indigenous vaccine targeting Plasmodium falciparum, the deadliest ...

Chandigarh: The PGI is at the forefront of India's efforts to develop indigenous solid tumour cancer drugs, serving as one of the four pivotal Phase 1.

Reconciling invoices and payments in clinical research has long been a fragmented, time-consuming, and error-prone task. Sites often use multiple siloed systems to manage invoices, while Sponsors and ...

ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, has been honoured in the ...

The enrolment for phase III clinical trials of India's first dengue vaccine, DengiAll, is expected to be completed by October ...

Phase-III trial of indigenous one-shot dengue vaccine by Panacea Biotec shows promising results in India, aiming for ...